JPWO2020243199A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020243199A5
JPWO2020243199A5 JP2021570378A JP2021570378A JPWO2020243199A5 JP WO2020243199 A5 JPWO2020243199 A5 JP WO2020243199A5 JP 2021570378 A JP2021570378 A JP 2021570378A JP 2021570378 A JP2021570378 A JP 2021570378A JP WO2020243199 A5 JPWO2020243199 A5 JP WO2020243199A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
unsubstituted
heterocyclyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534501A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034746 external-priority patent/WO2020243199A1/fr
Publication of JP2022534501A publication Critical patent/JP2022534501A/ja
Publication of JPWO2020243199A5 publication Critical patent/JPWO2020243199A5/ja
Pending legal-status Critical Current

Links

JP2021570378A 2019-05-30 2020-05-27 三環式化合物 Pending JP2022534501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
US62/854,597 2019-05-30
PCT/US2020/034746 WO2020243199A1 (fr) 2019-05-30 2020-05-27 Composés tricycliques

Publications (2)

Publication Number Publication Date
JP2022534501A JP2022534501A (ja) 2022-08-01
JPWO2020243199A5 true JPWO2020243199A5 (fr) 2023-05-30

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570378A Pending JP2022534501A (ja) 2019-05-30 2020-05-27 三環式化合物

Country Status (18)

Country Link
US (1) US11136321B2 (fr)
EP (1) EP3976618A4 (fr)
JP (1) JP2022534501A (fr)
KR (1) KR20220016177A (fr)
CN (1) CN113906029A (fr)
AU (1) AU2020282707A1 (fr)
BR (1) BR112021023967A2 (fr)
CA (1) CA3138938A1 (fr)
CL (1) CL2021003139A1 (fr)
CO (1) CO2021017202A2 (fr)
EA (1) EA202192760A1 (fr)
IL (1) IL287813A (fr)
MA (1) MA56058A (fr)
MX (1) MX2021014458A (fr)
PE (1) PE20220427A1 (fr)
SG (1) SG11202113214QA (fr)
TW (1) TW202110845A (fr)
WO (1) WO2020243199A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021387908A1 (en) * 2020-11-24 2023-06-22 Aligos Therapeutics, Inc. Tricyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701273D0 (en) * 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
WO2008157273A1 (fr) * 2007-06-14 2008-12-24 Smithkline Beecham Corporation Composés chimiques
AU2013404035B2 (en) 2013-10-29 2017-04-20 Medivir Ab Quinazoline based respiratory syncytial virus inhibitors
AU2017231817B2 (en) 2016-03-09 2021-02-25 Emory University Elimination of hepatitis B virus with antiviral agents
CN110066278B (zh) * 2017-06-01 2021-06-08 广东东阳光药业有限公司 稠合三环类化合物及其在药物中的应用

Similar Documents

Publication Publication Date Title
ES2831333T3 (es) Moduladores de la proteína nuclear de la hepatitis B
KR102666477B1 (ko) 글루타민 유사체의 프로드럭
JP2010514768A5 (fr)
JP4493337B2 (ja) 3−β−D−リボフラノシルチアゾロ[4,5−d]ピリミジンヌクレオシド及びその使用
ES2342069T4 (es) Ligandos de tlr7 para el tratamiento de la hepatitis c.
ES2325088T3 (es) Compuestos utiles en el tratamiento de hiv.
JP6860585B2 (ja) 非環状抗ウイルス 優先出願の参照による組み込み
JP2020505396A5 (fr)
ES2272054T3 (es) Uso de compuestos de n-sustituido-1,5-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
JP2023531524A (ja) 1’-シアノヌクレオシド類似体及びその使用
JP2018500372A5 (fr)
RU2011139180A (ru) Комбинация нуклеозидного ингибитора полимеразы и макроциклического ингибитора протеазы и ее применение для лечения гепатита с, фиброза печени и нарушенной печеночной функции
JP2010526834A5 (fr)
RU2008152171A (ru) Новые ингибиторы вирусной репликации гепатита с
CA2597213A1 (fr) Compositions et methodes permettant de traiter ou de prevenir les infections par les flaviviridae
KR890006540A (ko) I-데속시노지리마이신 및 i- 데속시만노노지리마이신의 n-치환유도체, 이들의 제조방법 및 의약제로서의 용도
JP2007532479A5 (fr)
JP2007531749A5 (fr)
JPH11512083A (ja) C型肝炎の治療における1,3−オキサチオランヌクレオシドアナログ
RU2007118729A (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а
JP2004525142A5 (fr)
US20090274686A1 (en) Nucleoside phosphonate derivatives
ES2229820T3 (es) Terapia de combinacion ribavirina-interferon alfa para erradicar el hcv-rna detectable en pacientes con infeccion por hepatitis c cronica.
JP2017521433A5 (fr)
JP2011518168A5 (fr)